Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Regulatory News (TSTL)

Share Price Information for Tristel (TSTL)

Share Price is delayed by 15 minutes
Get Live Data
385.00    -7.50 (-1.91%)
Bid:
380.00
Ask:
390.00
Spread: 10.00 (2.632%)
Market Cap: £184.79m
TSTL Live PriceLast checked at - London Stock Exchange

Intraday Tristel Share Chart

Acquisition

29 Aug 2006 07:01

Tristel PLC29 August 2006 For release29 August 2006 Tristel Plc Technology Acquisition Agreement with IVC Limited, New Zealand Tristel plc ("Tristel"), the chlorine dioxide specialist that supplies infectionand contamination control products to healthcare and institutionalestablishments and the pharmaceutical and food processing industries, announcesthat it has entered into a technology acquisition agreement with IVC Limited, ("IVC"). IVC is Tristel's New Zealand distributor and its principal shareholderis Mark Fraundorfer, an internationally renowned Urologist. Under the terms of the agreement IVC transfers to Tristel the design and patentrights to two inventions which it has created to work specifically withTristel's chlorine dioxide chemistry. The inventions are a sterilizing traysystem which enables single use decontamination of endoscopic equipment and ahygiene work station which enables Tristel's highly effective sporicidalchemistry to be easily applied to floors and walls in high risk wards anddepartments of hospitals. IVC has funded the design and development process to date and transfers theintellectual property created in return for unspecified future royalties. Commenting upon the agreement, Paul Swinney, Chief Executive of Tristel, said: "Outside of the most advanced healthcare markets, where endoscopes are mainlyprocessed in sophisticated and costly automated machines, the majority ofendoscopes are disinfected in basic trays and sinks. These can only holddisinfectant liquids that have to be used repeatedly for many instruments over aperiod of many hours or even days. "The Tristel tray system, combined with Tristel's novel burstable sachet,Tristel Fusion, enables the disinfectant to be used once and to be dedicated toone instrument only. "This achieves one of the key features of the most sophisticated endoscopereprocessing machines at a fraction of their cost, and will help Tristelpenetrate many overseas markets with its chlorine dioxide disinfectants." Tristel plc Parkgreen Communications Ltd Paul Swinney, Chief Executive Paul McManusPaul Barnes, Finance Director Tel 020 7493 3716Tel: 01638 721 500 Mob: 07980 541 893http://www.tristel.com paul.mcmanus@parkgreenmedia.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
9th Sep 20107:00 amRNSTrading Statement
1st Jul 20107:00 amRNSDirector/PDMR Shareholding
28th Jun 201010:52 amRNSDirector/PDMR Shareholding
8th Jun 20104:01 pmRNSDirector/PDMR Shareholding
7th Jun 20105:15 pmRNSDirector/PDMR Shareholding
2nd Jun 20103:23 pmRNSDirector/PDMR Shareholding
2nd Jun 20107:00 amRNSDirectorate Change
19th Mar 20107:00 amRNSDirector/PDMR Shareholding
8th Mar 20107:00 amRNSHalf Yearly Report
25th Feb 20107:00 amRNSChange of Adviser
15th Dec 200912:03 pmRNSAGM Statement
4th Dec 20097:00 amRNSDirector/PDMR Shareholding
25th Nov 200910:35 amRNSGeneral Meeting
9th Nov 20097:00 amRNSPlacing and Notice of General Meeting
28th Oct 20099:14 amRNSDividend
13th Oct 20098:35 amRNSGrant of options
12th Oct 20097:00 amRNSFinal Results
18th Sep 20097:00 amRNSLicensing agreement
3rd Jul 200911:28 amRNSDirectors' Dealing
3rd Jul 20097:00 amRNSAcquisition and Placing
11th May 20097:00 amRNSExclusive UK distribution agreement
17th Mar 20099:35 amRNSCorrection to Record Date
16th Mar 20097:00 amRNSHalf Yearly Report
9th Mar 20097:00 amRNSNew infection control range for dental practices
8th Jan 20097:00 amRNSDirector/PDMR Shareholding
17th Dec 20087:00 amRNSAGM Statement
7th Nov 20087:00 amRNSNHS Supply Chain listing
6th Oct 20087:00 amRNSFinal Results
3rd Sep 20089:05 amRNSGrant of Patent
25th Jul 20087:00 amRNSTrading update & Notice of re
7th Jul 200810:55 amRNSDirector/PDMR Shareholding
1st Jul 20087:00 amRNSGrant of Patent
23rd Jun 20087:00 amRNSSupply and Distribution Agree
28th May 200811:32 amRNSDirector/PDMR Shareholding
2nd May 20087:00 amRNSDirector/PDMR Shareholding
4th Apr 20085:04 pmRNSCorrection -Board Appointment
4th Apr 20087:01 amRNSDirector/PDMR Shareholding
3rd Apr 20087:00 amRNSBoard Appointment
27th Mar 20089:26 amRNSDirector/PDMR Shareholding
12th Mar 20081:30 pmRNSIssue of Equity
3rd Mar 20087:01 amRNSNew supply agreement
3rd Mar 20087:00 amRNSInterim Results
7th Feb 20087:00 amRNSNotice of Results
6th Feb 20081:19 pmRNSRe. Tristel Italia srl
3rd Jan 20083:29 pmRNSGrant of patent
11th Dec 200711:42 amRNSAGM Statement
5th Nov 200712:38 pmRNSDirector/PDMR Shareholding
29th Oct 20071:01 pmRNSDividend
29th Oct 20077:01 amRNSFinal Results
16th Oct 20077:00 amRNSChange of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.